| | | |  | | | | By Allison DeAngelis Adobe The company, based in Cambridge, Mass., was developing drugs for repeat expansion disorders such as Huntington's disease. Read More | | By Megan Molteni Adobe The work opens the door to using such human-rodent chimeras to better understand what goes wrong in neurological and psychiatric conditions. Read More | | By Adam Feuerstein Alex Hogan/STAT Results from this study will be announced by year's end, but the timing of the deal suggests Merck and Moderna have seen encouraging data. Read More | | Sponsor content by ICR Westwicke The 'Innovator's Burden': How to navigate having a new approach in the skeptical healthcare industry While the industry loves true innovations – and the brilliant minds who envision them – being an innovator is not for the faint of heart. We call it the “Innovator's Burden.” Understanding the challenges, planning for them, and using proven communications strategies, the Innovator's Burden can be eased, and the company can realize the potential of their discovery. It's not easy, mind you, but maybe it's not supposed to be. | | By Andrew Joseph JEFF KOWALSKY/AFP via Getty Images Previously, the newer versions of the Covid booster shots were only available to adults and kids as young as 12. Read More | | By Jayne Williamson-Lee Adobe An analysis of thousands of patient messages show that women physicians are much more likely to go "untitled" than are male physicians. Read More | | By Ed Silverman Adobe At issue has been the approach taken by the FDA to approve the use of active ingredients, which could be used to make compounded medicines. Read More | | By Ann Ledbetter Hannah McKay - Pool/Getty Images Maternal deaths and preterm births are far higher in the U.S. than in other similar countries. Relying more on midwives could close that gap. Read More | |
No comments